Bardy Diagnostics, Inc.

Cardiac monitoring company iRhythm Technologies is not giving up on providing its Zio XT 14-day cardiac monitoring system to Medicare beneficiaries and will continue to provide Zio XT to these users

The ongoing dispute between payers and manufacturers over Medicare reimbursement rates for continuous cardiac monitoring is unlikely not be resolved soon. Since the end of January, a consortium of mon

[ Update: On 12 July, the Delaware Court of Chancery ordered Hillrom to proceed with its proposed acquisition of Bardy Diagnostics, denying Hillrom's claim of a Material Adverse Event under the te

Boston Scientific is the latest company to make a big investment in the fast-growing remote diagnostics and services market with an agreement to buy ambulatory cardiac monitoring company Preventice